Stock Information
Syndax Pharmaceuticals Inc (SNDX)
Ticker Symbol: SNDX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,185.91 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.3003
Revenue (TTM): $1.99 M
Dividend Yield: N/A%
ROE: -206.62%
Latest News
-
Kura Oncology: Commercialization In AML Presents Asymmetric Upside
Thu, Apr 2, 2026 8:15 AM
-
Goldman Sachs Maintains Buy on Syndax Pharmaceuticals, Raises Price Target to $34
Wed, Apr 1, 2026 1:49 PM
-
Mizuho Maintains Outperform on Syndax Pharmaceuticals, Lowers Price Target to $43
Tue, Mar 31, 2026 9:30 AM
Key Financials
Financial data not available
